CRISPR Insider™

CRISPR News and Information from Around The World

< CRISPR Insider™ home

Home Page

Crispr News

  • Intellia Therapeutics: A Leader in CRISPR/Cas9 Genome Editing ... - Best Stocks
    April 2, 2023
  • CRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni ... - MarketBeat
    April 1, 2023
  • Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics - The Motley Fool
    April 1, 2023
  • Pediatric Cancer Cell Atlas Uncovers Clues About Cancer Drivers ... - GenomeWeb
    March 31, 2023
  • Cutting With CRISPR: Assessing Safety as Technology Moves Into ... - Technology Networks
    March 31, 2023
  • Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce ... - Cancer Discovery
    March 31, 2023
  • Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Yahoo Finance
    March 31, 2023
  • This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market ... - Nasdaq
    March 31, 2023
  • Genome-wide tiled detection of circulating Mycobacterium ... - Nature.com
    March 31, 2023
  • 5 Bargain-Basement Stocks to Buy Right Now - Nasdaq
    March 31, 2023
  • Buy Crispr Therapeutics On Approval Odds (NASDAQ:CRSP) - Seeking Alpha
    March 31, 2023
  • Opportunity in the CRISPR Gene Editing Market | High Market ... - Medgadget
    March 31, 2023
  • CRISPR cats and dogs? Royal Society for the Prevention of Cruelty ... - Genetic Literacy Project
    March 31, 2023
  • CRISPR pioneer Jennifer Doudna to speak April 4 in Chicago - Northwestern Now
    March 31, 2023
  • Brassinosteroid gene regulatory networks at cellular resolution in ... - Science
    March 30, 2023
  • CRISPR editing in the lung with novel lipids - Nature.com
    March 30, 2023
  • Nucleotide metabolism regulates human telomere length via ... - Nature.com
    March 30, 2023
  • One-Time Treatment: Base Editing Shows Promise vs. SMA - Genetic Engineering & Biotechnology News
    March 30, 2023
  • 2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It - Nasdaq
    March 30, 2023
  • Editing the cell's transcripts - Drug Discovery News
    March 30, 2023

Nobel Prize winning CRISPR biochemist Jennifer Doudna and noted author Walter Isaacson discuss her work and his profile of her. The new book is titled “The Code Breaker,” release date March 9, 2021. CBS Sunday Morning, March 7, 2021

CRISPR-Cas9 vs. Cancer – A system to successfully pinpoint and destroy metastatic brain and ovarian cancer cells in mice has been reported by Tel Aviv University Researchers in the journal Science Advances. Tel Aviv University video. November 16, 2020

advances.sciencemag.org

Tel Aviv University cancer researcher Dr. Dan Peer speaks with journalist Maria Menounos about efforts to treat glioblastoma and ovarian cancer in mice using CRISPR-Cas9 to target and kill cancer cells. BETTER TOGETHER video. December 29, 2020

DOUDNA, CHARPENTIER WIN NOBEL PRIZE IN CHEMISTRY FOR CRISPR Cas9 DEVELOPMENT.October 7, 2020


Nobel Foundation Press Release

 

Reaction From Dr. Emmanuelle Charpentier Obtained by CRISPRInsider: “Please know that I am thrilled with this amazing news. I am truly honored to have been chosen as a recipient of this most prestigious award and herewith join the very distinguished group of former laureates.”
Crispr Insider reports on and helps ignite the DNA revolution currently underway.--This revolution to engineer DNA is transforming human life in ways unimaginable since Watson and Crick discovered DNA in 1953.

CRISPR Cas9 v. Banana Blight – Can genes in the world’s most popular variety of banana be edited to fight a fungus threatening the global supply? Tropic Biosciences CEO Gilad Gershon answers questions from CRISPRInsider’s Bob Males. London, August 7, 2020

"Anything we can dream of in terms of biology and chemistry we can probably achieve through molecular technologies like editing." Dr. George Church, Professor at MIT & Harvard. Topic: The man of the future will quite likely be unrecogizable to current humans in 250 years.
Boston, June 5, 2018

Part 1 – Dr. George Church, Professor at MIT & Harvard. Topics: how the Human Genome Project led to CRISPR gene editing; consumer uses of genetic information; immunotherapy. Boston, June 5, 2018

Part 2 – Dr. George Church, Professor at Harvard & MIT. Topics: Can CRISPR gene editing reinvent man?; most desireable genes; unintended consequences; treating cancer; CRISPR preps pigs for transplantation. Boston, June 5, 2018

Part 3 – Dr. George Church. Topics: FDA hold on CRISPR clinical trial; sickle cell & thalassemia. Boston, June 5, 2018

Part 4 – Dr. George Church: CRISPR “very exciting for plant and animal agriculture.” Boston, June 5, 2018

Part 5 – Dr. George Church: Monitor the spread of synthetic biology: “There should be licensing and surveillance.” Boston, June 5, 2018

Part 6 – Dr. George Church

Dr. Feng Zhang discusses his work at CRISPRcon18. Boston, June 4, 2018

Dr. Duanqing Pei, Chinese Academy of Sciences: Why Chinese CRISPR research is focusing on Beta Thalassemia and Sickle Cell Diseases. Boston, June 5, 2018

Dr. Duanqing Pei, Chinese Academy of Sciences: Clinical trials guidelines and principles “closely related” in U.S. and China. Boston, June 5, 2018

Pat 1, Mice Against Ticks. Can CRISPR gene editing wipe out Lyme Disease? Carrie Fyler, PhD, comments. Boston, June 5, 2018. 2:34.

Part 2, Mice Against Ticks. A Massachusetts biology teacher offers a possible timeline for a test plan to eradicate Lyme Disease on Martha’s Vineyard and Nantucket Islands. Boston, June 5, 2018. 4:11

Part 3, Mice Against Ticks. How the public has responded, so far, to the Mice Against Ticks gene editing proposal. Boston, June 5, 2018. :43

Mice Against Ticks, Part 4. How Lyme Disease could get stopped on Martha’s Vineyard and Nantucket Islands using the gene editing tool CRISPR CAS9 on field mice to reduce the incidence of this tick-borne disease. Boston, June 5, 2018. :51

Dr. Tom Barnes, Intellia Therapeutics: Why recent CRISPR CAS9/Cancer headlines are “unwarranted.” NYC, June 21, 2018

Dr. Tom Barnes, Intellia Therapeutics, assesses the CRISPR clinical push in China. NYC, June 21, 2018. 1:45

Dr. Tom Barnes, Intellia Therapeutics: FDA’s hold on CTX0001 “might be nothing.” NYC, June 21, 2018. :47

Dr. Tom Barnes, Intellia Therapeutics, addresses the cost complexities of personalized medicine. NYC, June 21, 2018

Dr. Tom Barnes, Intellia Therapeutics, discusses newest CRISPR Cas9 U.S. patent for Doudna and Charpentier. NYC, June 21, 2018

Dr. Tom Barnes, Intellia Therapeutics: The areas we’re’ working on with CRISPR. NYC, June 21, 2018

CRISPR News from China

  • Russia registered a new crown of the vaccine was the top magazine critics questioned;China’s first HIV pre-exposure prophylaxis drug approved
    August 14, 2020
  • West Media:scientists are trying to be“genetic scissors”for the fight against the new Crown virus _ the message…
    August 12, 2020
  • West Media:scientists are trying to be“genetic scissors”for the fight against the new Crown virus
    August 11, 2020
  • Scientists in the development of early use of CRISPR knock-out genetic information
    August 10, 2020
  • “Gene writing”can be broken CRISPR limitations? This cutting-edge, or the rewriting of genetic disease in the future
    August 10, 2020
  • From today 185 billion USD m & a,see the health events to the medical health industry opportunities
    August 6, 2020
  • CRISPR-base editor“Nova”ABE8e exactly how the ratio of early ABEs fast 1100 times?
    August 6, 2020
  • Anhui Wanjia hotline:secondary view WAN West Pharmaceutical flood relief in action
    August 5, 2020
  • Science heavy! The CRISPR field two“gurus”cooperation in depth analysis of single base editor…
    August 4, 2020
  • With CRISPR diagnosis of the underlying methodology of an exclusive patent,Tolo creatures won million strategic financing
    August 4, 2020
  • Focus on CRISPR diagnostic techniques,Tolo creatures won tens of millions of dollars financing
    August 4, 2020
  • Nat Metab | genome-wide CRISPR screening found that type I diabetes new therapeutic targets—RNLS
    August 3, 2020
  • 2020 7 on CRISPR/Cas the latest research progress
    July 30, 2020
  • Researchers at the largest of the CRISPR system in the positioning mechanism
    July 30, 2020
  • From R & D to filings,gold, Rui for CRISPR applications in Cell Therapy provides one-stop new programme
    July 29, 2020

Contact

    • Nothing to display ...
    Copyright 2020 CrisprInsider.com